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Abstract: Biomedical and clinical research is gradually shifting from the tradi-
tional “one-size-fits-all” approach to the new paradigm of personalized medicine.
An important step in this direction is to identify the treatment by covariate in-
teractions. We consider the setting in which there are potentially a large number
of covariates of interest. Although a number of novel machine learning method-
ologies have been developed in recent years to aid in treatment selection in this
setting, few, if any, have adopted formal hypothesis testing procedures. In this
article, we present a novel testing procedure based on m-out-of-n bootstrap that
can be used to sequentially identify variables that interact with treatment. We
study the theoretical properties of the method and show that it is more effec-
tive in controlling the type I error rate and achieving a satisfactory power as
compared to competing methods, via extensive simulations. Furthermore, the
usefulness of the proposed method is illustrated using real data examples, both
from a randomized trial and from an observational study.
Key words and phrases: Double robustness; Forward stepwise testing; m-out-of-n
bootstrap; Non-regular asymptotics; Personalized medicine.
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1. Introduction
Due to patient heterogeneity in response to various aspects of any
treatment program, biomedical and clinical research is gradually shifting
from the traditional “one-size-fits-all” treatment settings to the cutting-
edge paradigm of personalized medicine. An important step in this direc-
tion is to identify the treatment by covariate interactions. In the conven-
tional approach, investigators would first identify a set of key covariates.
Treatment by covariate interactions would then be examined either by com-
paring treatment vs. control in subgroups defined by the key covariates, or
by testing the regression coefficients of the treatment by covariate interac-
tion terms in a multivariable linear model. These approaches, however, are
either infeasible or unreliable due to overfitting, when there is a moderate
to large number of covariates under consideration.
In recent years, a number of novel methodologies have been developed to
identify treatment by covariate interaction effects based on a large set of co-
variates, with the ultimate goal of optimizing treatment selection. This in-
cludes ranking methods (Gunter, Zhu and Murphy 2011; Tian and Tibshirani
2011; Chen et al. 2017), regression based methods (Qian and Murphy 2011;
Lu, Zhang and Zeng 2013; Tian et al. 2014; Fan, Lu and Song 2016), weighted
classification type learning methods (Orellana, Rotnitzky and Robins 2010,
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Zhang et al. 2012; Zhao et al. 2012; Huang and Fong 2014; Liu et al. 2018),
tree based methods (Su et al. 2008; Laber and Zhao 2015; Tsai et al. 2016),
and functional data approaches (McKeague and Qian 2014; Ciarleglio et al.
2015; Laber and Staicu 2018), to mention a few. A major gap in this litera-
ture, however, has been the scarcity of formal hypothesis testing procedures
that take variable selection into account.
There is a limited number of papers that discussed novel hypothesis
testing approaches for subgroup identification of enhanced treatment effect.
Shen and He (2015) developed a likelihood-based test for the existence of a
subgroup based on linear logistic-normal mixture models. Fan, Song and Lu
(2017) proposed a method to test and identify a subgroup using change-
point techniques. Wager and Athey (2018) investigated a forest-based method
for treatment effect estimation and inference. Shi, Song and Lu (2019) pro-
posed a nonparametric test to assess the incremental value of a given set
of new variables in optimal treatment decision making conditional on an
existing set of prescriptive variables. These methods focused on the test
of non-linear treatment effects, and worked well with a relatively small set
of covariates. Although Shi, Song and Lu (2019) considered application of
their method in a forward stepwise fashion and studied its variable selection
properties, the derived p-value loses its interpretation when used with for-
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ward selection. In the presence of large number of covariates, Shen and Cai
(2016) proposed a kernel based method to identify whether there is in-
teraction between the treatment and a group of covariates; however, this
is applicable only to a randomized trial setting. Zhao, Small and Ertefaie
(2017) considered a lasso based inference approach to identify informative
covariates under the condition that both the propensity score and the main
effect of covariates on outcome are well estimated.
In a methodologically analogous setting, gene-environment interaction
has been extensively studied in the field of genetics. The most common
approach is to test the interaction of each genetic marker and an environ-
mental exposure separately, and then adjust for multiple comparison. To
improve power and to reduce the burden of multiple comparison, several
global tests have been proposed to assess the joint interaction effect be-
tween a marker set and an environmental variable (e.g. Lin et al. 2013;
Marceau et al. 2015). The validity of these methods, however, rely on ap-
proximately correct model of the main effects of markers and environmental
factors.
In the current paper, we consider data from either randomized trials
or observational studies. We aim to identify covariates that interact with
treatment, among a large set of candidate covariates, via a sequential testing
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procedure. First, a marginal screening test is used to detect whether there
is any covariate that significantly interacts with treatment. If the test is sig-
nificant, then we proceed to test whether there are additional treatment by
covariate interactions in a forward stepwise fashion. The procedure contin-
ues until the p-value exceeds the pre-specified level of significance. Forward
stepwise regression has been extensively studied (Barron and Cohen 2008;
Donoho and Stodden 2006; Wang 2009; Ing and Lai 2011). However, the
vast majority of the literature focused on studying the variable selection
consistency properties, instead of hypothesis testing. In real applications,
to enhance reproducibility, clinicians would often like to have some inferen-
tial guarantees for the selected covariates, and variable selection consistency
theory alone would not satisfy their needs. This type of selective infer-
ence problems have drawn a lot of attention from statisticians, and various
methods have been proposed in the prediction literature (e.g., Bu¨hlmann
2013; Zhang and Zhang 2014; Lockhart et al. 2014; van de Geer et al. 2014;
McKeague and Qian 2015; Ning and Liu 2017; Luedtke and van der Laan
2018).
We propose to calibrate our test statistic either by directly sampling
from the null (if it is estimable) or by using the m-out-of-n bootstrap. The
m-out-of-n bootstrap is a general tool for conducting valid statistical in-
SEQUENTIAL TEST OF INTERACTION EFFECTS 6
ference for non-regular parameters (Shao 1994; Bickel, Gotze and van Zwet
1997). It is the usual nonparametric bootstrap (Efron 1979) except that the
resample size m is of a smaller order than the original sample size n. With
an appropriate choice of m, the m-out-of-n bootstrap acts as a smoothing
operation on the empirical distribution of the data. Data-driven methods
for choosingm in various contexts were proposed in Hall, Horowitz and Jing
(1995), Lee (1999), Bickel and Sakov (2008) and Chakraborty, Laber and Zhao
(2013). In the current paper, an adaptive choice of m is developed. The
proposed test is valid as long as either the propensity score is known (or
modeled correctly) or the main effects model of covariates on outcome is
correctly specified.
The paper is organized as follows. In Section 2, we set up the framework
and describe the initial marginal screening test for identifying the variable
that most strongly interacts with treatment in the randomized trial setting.
In Section 3, we present the sequential test procedure. In Section 4, we ex-
tend our method to allow for double robustness, which is particularly useful
in observational studies where the propensity score model is unknown. In
Section 5, we conduct simulations comparing proposed methods with exist-
ing competitors, and illustrate the methods using two data examples. We
conclude with a discussion in Section 6. Proofs of the theorems and details
7of simulations are presented in the Supplementary Materials.
2. Marginal Screening Test for Randomized Trials
2.1 Marginal regression
Suppose we are given pre-treatment information, treatment assignment,
and outcomes from n patients. Further suppose there are only two com-
peting treatments A ∈ {0, 1}. Let X ∈ Rp be the vector of pre-treatment
variables, and Y be a scalar outcome. Let q0(x) := P (A = 1|X = x) be
the propensity of receiving treatment 1 in the observed data as a function
of pre-treatment variablesX = x. In this section and Section 3, we assume
that the data come from a randomized trial, so q0(x) is known.
We frame the problem in terms of the model
Y = h0(X) + (α0 +X
Tβ0)A+ ǫ, (2.1)
where β0 ∈ Rp, h0(X) := E(Y |X, A = 0), and the error term ǫ has mean
zero, finite variance, and is uncorrelated with A−q0(X) and (A−q0(X))X.
The term α0 +X
Tβ0 models T (X) := E(Y |X, A = 1)− E(Y |X, A = 0),
the causal treatment effect for patients with pre-treatment information X ;
thus, (α0 + X
Tβ0)A is the treatment-by-covariate interaction model. In
this paper, we propose a sequential testing procedure to identify covariates
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that interact with treatment.
As an initial step, we are interested in testing whether there is any
treatment-by-covariate interaction. That is, we want to test
H0 : β0 = 0 vs. Ha : β0 6= 0. (2.2)
Our proposed method is based on fitting p working marginal regression
models, and conducting a single test on the marginal regression coeffi-
cient of the most informative predictor of the causal treatment effect T (X).
Specifically, we can write E(Y |X, A) = E(Y |X) + T (X)W , where W :=
A− q0(X) (see Robins 1994). For k = 1, . . . , p, consider the working model
T (X) = αk + θkXk. The kth marginal regression model aims to estimate
(αk, θk) = argmin
(α,θ)
E
{[
Y −E(Y |X)− (α + θXk)W
]2}
. (2.3)
And the index of the most informative predictor of T (X) is
k0 =argmin
k
E
{[
Y − E(Y |X)− (αk + θkXk)W
]2}
.
By taking first order derivative of (2.3) with respect to (α, θ) and noting
that E(W |X) = 0, we have under model (2.1),
θk =
E
[
W (Y − E(Y |X))X ′k
]
E(WX ′k)
2
=
Cov(WX ′k,WX
Tβ0)
E(WX ′k)
2
and k0 = argmax
k
∣∣Corr(WX ′k,WXTβ0)∣∣,
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where X ′k = Xk−E(W 2Xk)/EW 2. Assume that k0 is unique when β0 6= 0.
We can verify that β0 = 0 if and only if θk = 0 for all k = 1, . . . , p. Thus
hypothesis (2.2) is equivalent to
H0 : θ0 = 0 vs. Ha : θ0 6= 0, (2.4)
where θ0 = θk0 . Using randomized trial data, we can estimate k0 and θ0 by
kˆn =arg min
k∈{1,...,p}
Pn
{[
Y − φˆn(X)− (αˆk + θˆkXk)W
]2}
and θˆn := θˆkˆn =
{
Pn
[(
WXˆ ′
kˆn
)2]}−1
Pn
[
W (Y − φˆn(X))Xˆ ′kˆn
]
,
respectively, where Pn denotes the sample average, φˆn(X) is an estimate
of E(Y |X), (αˆk, θˆk) = argmin(α,θ)
{
Pn
[
Y − φˆn(X)− (α+ θXk)W
]2}
, and
Xˆ ′k = Xk − Pn(W 2Xk)/PnW 2.
Our first result gives the asymptotic distribution of θˆn.
Theorem 1. Assume i) EX4k <∞ for k = 1, . . . , p; ii) the error term ǫ in
model (2.1) has mean zero, finite variance and is uncorrelated with W and
WX; and iii) φˆn(X) is estimated from a P -Donsker class of measurable
functions, and there exists some φ˜(X) such that E[φˆn(X) − φ˜(X)]4 P→ 0
for some φ˜(X) that is fourth moment integrable as n→ ∞. Suppose k0 is
unique when β0 6= 0. Then under model (2.1),
n1/2(θˆn − θ0) d→ Zk0
E[WX ′k0 ]
2
1β0 6=0 +
ZK
E[WX ′K ]
2
1β0=0,
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where X ′k = Xk − E(W 2Xk)/EW 2, K = argmaxk=1,...,p Z2k/E(WX ′k)2, and
(Z1, . . . , Zp)
T is a mean-zero normal random vector with covariance matrix
Σ given by that of the random vector with components
WX ′k
{
Y − φ˜(X)− E[W (Y − φ˜(X))]
EW 2
W − E[WX
′
k(Y − φ˜(X))]
E(WX ′k)
2
WX ′k
}
for k = 1, . . . , p, and Σ is assumed to exist.
Remark 1. The uniqueness of k0 is assumed in order to make sure that
the parameter θ0 is well defined under Ha. Note that for hypothesis testing
purpose, the test is always calibrated under the null distribution, which
does not rely on this condition. Nonetheless, this condition can be removed
with a slight modification of hypothesis (2.4) and the test statistic. A mod-
ified version of Theorem 1 without the uniqueness condition is presented in
Section S3 of the Supplementary Materials.
Remark 2. φˆn(X) is an estimate of E(Y |X), which can be obtained
via sample mean of Y , (regularized) regression from a linear model, or
other non-parametric methods based on a Donsker class of functions that
guarantee the convergence of φˆn(X) to some function φ˜(X). The result
does not require φˆn(X) to be a consistent estimate of E(Y |X). However,
a good estimate of E(Y |X) may help reduce the variance of each Zk, and
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thus θˆn. For example, assume q0(X) = 1/2. We can verify that
Var(Zk) =Var
(
WX ′k
[
E(Y |X)− φ˜(X)])+Var (WX ′kǫ)
+ Var
(
W 2X ′k
[
(X − EX)Tβ0 − θkX ′k
])
.
So the variance of each Zk is minimized when φ˜(X) = E(Y |X).
One way to test θ0 = 0 is to estimate the null distribution of n
1/2θˆn by
setting β0 = 0 in Theorem 1 and replacing φ˜(X) with φˆn(X) and expec-
tation with sample average, respectively. The p-value can be calculated by
comparing the observed test statistic n1/2θˆn with the estimated null distri-
bution. Alternatively, below we introduce an m-out-of-n bootstrap method
to estimate the asymptotic distribution of θˆn. This method can then be
easily extended to cases where the null distribution is difficult to estimate
(see Section 4).
2.2 The m-out-of-n bootstrap
The m-out-of-n bootstrap is a general tool to remedy bootstrap inconsis-
tency due to nonsmoothness. When the resample size m is of a smaller
order than n, the empirical distribution converges to the true distribution
at a faster rate than the analogous convergence of the m-out-of-n bootstrap
sample empirical distribution to the empirical distribution. Intuitively, this
implies that the empirical distribution converges to the true distribution
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first and thus bootstrap resamples behave as if they were drawn from the
true distribution.
For a selected resample size m, let θˆ∗m be the analog of θˆn based on
the bootstrap sample of size m. Theorem 2 below shows the bootstrap
consistency results. And the p-value can be calculated by comparing n1/2θˆn
with the distribution of m1/2(θˆ∗m − θˆn).
Theorem 2. Assume all conditions in Theorem 1 hold. Suppose m/n =
O(1)1β 6=0+o(1)1β=0, andm→∞ as n→∞. Thenm1/2(θˆ∗m−θˆn) converges
to the same limiting distribution as n1/2(θˆn−θ0) conditionally (on the data),
in probability.
A key challenge inm-out-of-n bootstrap is how to choosem. Bickel and Sakov
(2008) proposed an adaptive choice of m for constructing confidence inter-
vals for extrema, and proved that the chosen m satisfies the conditions in
Theorem 2. In our simulation studies, we have found that their approach,
when applied to our setting, did not achieve sufficient power, even though
it successfully controlled the type I error rate at the nominal level. Alter-
natively, in the context of Q-learning for estimating optimal dynamic treat-
ment regimes, Chakraborty, Laber and Zhao (2013) developed a scheme for
selecting m for inference of stage-1 regression parameters that adapts to the
degree of non-regularity. The tuning parameter involved in the procedure
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was chosen by double bootstrap, which is very time consuming in our set-
ting.
We extend Bickel and Sakov’s method for choosing m by adding a crude
pre-testing step with the goal of improving the power without inflating the
type I error rate. In particular, we define
rˆ = 1{|√nTn| < max(
√
c logn, upper α/(2p)-quantile of N(0, 1))}, (2.5)
where Tn = θˆn/σˆn is the conventional t-statistic based on the selected co-
variate Xkˆn , α is the level of significance, and c > 0 is a tuning parameter.
Since
√
nTn = Op(1) under H0 and
√
nTn = Op(
√
n) under Ha,
√
c logn
on the right hand side of (2.5) guarantees that rˆ
P→ 1θ0=0. The second
component within max on the right hand side of (2.5) is used to control the
type I error rate in case of small samples (see McKeague and Qian 2015).
Note that
√
c logn is an n-term, and the second term in (2.5) is a p-term.
Intuitively, when p is large, we expect that p plays a more important role
than n, and thus p-term should dominate the n-term, and vice-versa. The
tuning parameter c controls the balance of these two terms. We find c = 2
works well in various simulation settings, and suggest to use c = 2. If rˆ = 0,
we consider it as a crude rejection of H0, and propose to use the regular
n-out-of-n bootstrap to conduct a refined test. On the other hand, rˆ = 1
indicates that there might be some non-regularity, and we propose to use
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Bickel and Sakov’s method for choosing m. The complete algorithm is given
below.
1. Calculate rˆ defined in (2.5). If rˆ = 0, then choose mˆ = n. Otherwise,
continue with steps 2-4 to obtain Bickel and Sakov’s estimate mˆBS.
2. Consider a sequence of m’s of the form: mj = ⌈djn⌉, for j = 0, 1, 2, ..
and 0 < d < 1, where ⌈x⌉ denotes the smallest integer ≥ x, and d is
a tuning parameter.
3. For a given data set (with estimate θˆn), and for all j, define the boot-
strap empirical distribution function: RBmj (t, θˆn) =
∑B
b=1 1m1/2j (θˆ
∗,b
mj
−θˆn)≤t
/B,
where θˆ∗,bmj is themj-out-of-n bootstrap version of the estimate θˆn from
the b-th bootstrap sample, b = 1, . . . , B.
4. Following Bickel and Sakov (2008), set m as the minimizer of the sup-
norm of the successive differences between the bootstrap empirical dis-
tribution functions: mˆBS = argminmj supt |RBmj (t, θˆn)−RBmj+1(t, θˆn)|.
5. Output mˆ = (1− rˆ)n+ rˆmˆBS .
The tuning parameter d in Step 2 above can be viewed as a step size
since mj+1/mj ≈ d. Bickel and Sakov (2008) used d = 0.75 in their simula-
tion study, and reported robustness to other values. In our setting, we find
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that our method is pretty robust to the choice of d ∈ [0.7, 0.9] (see Section
S5.4 in the Supplementary Materials). In the simulation, we use d = 0.8
for our analysis.
3. Conditional Sequential Test for Randomized Trials
In the previous section, we have proposed a marginal screening test to
detect whether there is any covariate that interacts with treatment. If the
null in (2.4) is rejected, we will select kˆn as the most informative predictor
of the causal treatment effect. In this section, we extend our test to detect
additional treatment-by-covariate interactions.
The procedure is carried out in a forward stepwise fashion. At each
step, let J ⊂ {1, . . . , p} denote the index set such that {Xj : j ∈ J} have
been identified as having significant interaction with treatment in previous
steps. We aim to test whether there is any Xk ∈ {Xj : j ∈ JC} that
interacts with treatment. Specifically, we re-write model (2.1) as
Y = h0(X) + (α0 +X
T
Jβ0,J +X
T
JCβ0,JC)A+ ǫ (3.1)
where XJ = {Xj : j ∈ J} and XJC = {Xj : j ∈ JC}. The goal here is to
test β0,JC = 0.
Note that the index set J includes previously selected covariates. Thus
the the null hypothesis is actually a function of the observed data. This
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makes any sequential test beyond the initial step a conditional hypothesis
test. Nonetheless, under the alternative hypothesis, the selected covariate is
the truly most informative predictor at each step with probability tending
to 1 (see proofs of Theorems 1 and 3). So the index set J will converge to
a fixed set if the alternative hypotheses in previous steps are true.
For each k ∈ JC , let Uk = Xk−X˜
T
Jγk, where X˜J = (1,X
T
J )
T and γk =
argminγ
{
E
[
W (Xk − X˜
T
Jγ)
]2}
. That is, X˜
T
Jγk is the weighted projection
of Xk on the space spanned by X˜J . After algebraic simplification, we can
reformulate model (3.1) as
Y = h′0(X) + (α
′
0 +U
Tβ0,JC )A+ ǫ
′, (3.2)
where U = {Uk : k ∈ JC}; meanwhile
h′0(X) = h0(X) + q0(X)
[
X˜J − E(W
2X˜J)
EW 2
]T
λ,
α′0 =
E(W 2X˜
T
J )
EW 2
λ, and ǫ′ = ǫ+W
[
X˜J − E(W
2X˜J)
EW 2
]T
λ,
where λ = (α0,β
T
0,J)
T + Γβ0,JC with Γ being a parameter matrix with
columns consisting of {γk : k ∈ JC}.
Note that (3.2) is of similar form as model (2.1), withX replaced by U .
Thus to test β0,JC = 0 is equivalent to testing H0 : θ
′
0 = 0 vs. Ha : θ
′
0 6= 0,
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where
θ′0 =
E[W
(
Uk′
0
− E(W 2Uk′
0
)/EW 2
)
(Y −E(Y |X))]
E
{[
W
(
Uk′
0
−E(W 2Uk′
0
)/EW 2
)]2} = Cov(WUk′0,WUTβ0,JC)
E
(
W 2U2k′
0
) ,
and k′0 =arg max
k:k∈JC
∣∣Corr(WUk,WUT)β0,JC ∣∣.
Similar to the approach as described in Section 2, we can estimate θ′0
by θˆ′n using empirical quantities. The theorem below gives the asymptotic
distribution of θˆ′n and establishes the bootstrap consistency.
Theorem 3. Assume conditions i) - iii) in Theorem 1 hold. Suppose k′0 =
argmaxk:k∈JC
∣∣Corr(WUk,WUTβ0,JC )∣∣ is unique when β0,JC 6= 0. Then
under model (3.1),
n1/2(θˆ′n − θ′0) d→
Zk0
E(WUk0)
2
1β
0,JC
6=0 +
ZK
E(WUK)2
1β
0,JC
=0,
where K = argmaxkinJC Z
2
k/E(WUK)
2, and {Zk : k ∈ JC} is a mean-zero
normal random vector with covariance matrix Σ given by that of the random
vector with components
WUk
{
Y − φ˜(X)− E[WUk(Y − φ˜(X))]
E(WUk)2
WUk
−WX˜TJ
(
EW 2X˜JX˜
T
J
)−1
E
[
WX˜J
(
Y − φ˜(X)
)]}
for k ∈ JC, and Σ is assumed to exist.
Furthermore, Let θˆ′∗m be the m-out-of-n bootstrap analog of θˆ
′
n. As-
sume m/n = O(1)1β
0,JC
6=0 + o(1)1β
0,JC
=0, and m → ∞ as n → ∞. Then
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m1/2(θˆ′∗m − θˆ′n) converges to the same limiting distribution as n1/2(θˆ′n − θ′0)
conditionally (on the data), in probability.
The test of θ′0 = 0 can be conducted using either the sampling from null
procedure or the m-out-of-n bootstrap procedure as described in Section 2.
4. Extension to Allow for Double Robustness
Methods presented in previous sections are designed for scenarios where
the propensity score q0(X) is known. In this section, we further improve
the procedure to allow for double robustness in the sense that as long as
q0(X) or h0(X) is consistently estimated, a valid inferential procedure as
described previously can be established. This would be particularly useful in
observational studies, where the propensity score q0(X) is usually unknown.
We start with model (3.1), where the goal is to test β0,JC = 0 after
{Xj : j ∈ J} have been detected in previous steps. Note that the initial
test of β0 = 0 is a special case with J = ∅. Let qˆn(X) and hˆn(X) be the
estimates of q0(X) and h0(X) based on the data, and q˜(X) and h˜(X) be
the limit of qˆn(X) and hˆn(X), respectively (see Appendix A for conditions
on q˜(X) and h˜(X)). Denote W˜ := A− q˜(X).
To ensure double robustness, parameter estimates are often obtained
through solving estimating equations, known as G-estimation for structural
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mean models (Robins 1989, 1994). Past research in this area focused on
fitting a full causal treatment effect model restricted to a small set of vari-
ables, and studying the efficiency of the estimate. In this section, we apply
g-estimation marginally on each covariate and conduct test based on the se-
lected most informative covariate. Specifically, for each k ∈ JC , let (δk, ψk)
be the solution to
E
{
(X˜
T
J , Xk)
TW˜
[
Y − h˜(X)− (X˜TJδ +Xkψ)A
]}
= 0. (4.1)
This yields ψk =
[
E(AW˜L2k)
]−1
E[W˜ (Y − h˜(X))Lk], where Lk = Xk −
X˜
T
Jηk with ηk = argminη E
[
AW˜ (Xk − X˜
T
Jη)
2
]
.
To identify the most informative predictor, we need to identify the
optimization objective function corresponding to equation (4.1). Note that
under model (3.1), when q˜(X) = q0(X) or h˜(X) = h0(X) a.s., the left
hand side of (4.1) is equivalent to E
{
(X˜
T
J , Xk)
TAW˜
[
α0+X
Tβ0− (X˜
T
Jδ+
Xkψ)
]}
, where the quantity inside the expectation can be viewed as a
quasi-likelihood score function. Thus the solution to (4.1) satisfies
(δk, ψk) = argmin
(δ,ψ)
E
[
AW˜ (α0 +X
Tβ0 − X˜
T
Jδ −Xkψ)2
]
.
Intuitively, X˜
T
Jδk + Xkψk can be viewed as the best weighted linear ap-
proximation of the causal treatment effect T (X) = α0 +X
Tβ0 based on
(X˜J , Xk). Thus it is natural to define the most informative predictor in
20
{Xj : j ∈ JC} by
ko0 := arg min
k:k∈JC
E
[
AW˜ (α0+X
Tβ0−X˜
T
Jδk−Xkψk)2
]
= arg max
k:k∈JC
[
E
(
AW˜L2k
)
ψ2k
]
.
And the hypothesis of interest is
H0 : ψ0 = 0 vs. Ha : ψ0 6= 0, (4.2)
where ψ0 := ψko
0
. We can estimate ψ0 by ψˆn := ψˆkˆon, where ψˆk = Pn
[
Ŵ (Y −
hˆn(X))Lˆk
]/
Pn
(
AŴ Lˆ2k
)
and kˆon = argmaxk∈JC
[
ψˆ2kPn
(
AŴ Lˆ2k
)]
, with Ŵ =
A− qˆn(X), Lˆk = Xk − X˜
T
J ηˆk, and ηˆk = argminη Pn
[
AŴ (Xk − X˜
T
Jη)
2
]
.
The asymptotic distribution of ψˆn depends on the limiting behavior of
qˆn(X) and hˆn(X), and is difficult to estimate. Thus m-out-of-n bootstrap
will play an important role in obtaining valid inference for ψ0. Let ψˆ
∗
m de-
note the bootstrap analog of ψˆn. Below we give the asymptotic distribution
of ψˆn and prove the bootstrap consistency. A complete list of assumptions
is given in Appendix A.
Theorem 4. Suppose Assumptions (A1)-(A5) in Appendix A hold. Then
under model (3.1),
n1/2(ψˆn − ψ0) d→
Z˜ko
0
E(AW˜L2ko
0
)
1β
0,JC
6=0 +
Z˜K
E(AW˜L2K)
1β
0,JC
=0,
where K = argmaxk∈JC
[
Z˜2k/E(AW˜L
2
k)
]
, and {Z˜k : k ∈ JC} is a normal
random vector defined in (A.1).
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Furthermore, suppose Assumption (A6) in Appendix A holds, m/n =
O(1)1β
0,JC
6=0 + o(1)1β
0,JC
=0 and m → ∞ as n → ∞. Then under model
(3.1), m1/2(ψˆ∗m−ψˆn) converges to the same limiting distribution as n1/2(ψˆn−
ψ0) conditionally (on the data), in probability.
Note that, although the doubly robust method can be used for random-
ized trials, it may cause extra dispersion in variance in our setting. This
issue is discussed in Section S4 of the Supplementary Materials and via
simulations.
5. Numerical studies
In this section, we study the performance of the proposed sequential testing
procedure using simulated data, and give illustrations of the approach in
two real data examples.
5.1 Simulations
Below we briefly summarize simulations studies. See Section S5 in the
Supplementary Materials for the details of simulations.
In the randomized trial setting, we compare the proposed sampling from
null (NULL), m-out-of-n bootstrap (mˆ-boot), and the doubly robust m-
out-of-n bootstrap (mˆ-boot-DR) procedures with four competing methods:
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Likelihood ratio test (LRT), Multiple testing with Bonferroni correction
(BONF), n-out-of-n bootstrap (n-boot), and m-out-of-n bootstrap with m
chosen by Bickel and Sakov’s method ( mˆBS-boot). Three data generating
models are considered: i) null model; ii) model with one active interaction
term; and iii) model with two equally active interaction terms. The se-
quential testing procedure is carried out to evaluate the power (when there
is at least one active predictor in the candidate set) or type I error rate
(when there is no active predictor remaining in the candidate set) at each
step. The two proposed methods for randomized trials (NULL and mˆ-boot)
provide good control of type I error rate and good power in all cases. mˆ-
boot-DR, mˆBS-boot and LRT are less powerful as compared to NULL and
mˆ-boot. n-boot fails to control the type I error rate. When the components
ofX are uncorrelated, BONF is as good as our proposed methods in terms
of type I error rate control and power. However, when the components of
X are highly correlated, BONF is less powerful for large p (see Tables S1
and S2 in the Supplementary Materials).
In the observational study setting, we compare the mˆ-boot-DR method
with mˆBS-boot and n-boot methods. We consider four data generating
models: two with correctly specified q0(X) and mis-specified h0(X), two
with mis-specified q0(X) and correctly specified h0(X). Linear logistic
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regression model with adaptive lasso is used to estimate the propensity
score model q0(X), and linear regression with adaptive lasso is used to
estimate the main effect h0(X). The proposed mˆ-boot method provides
good control of type I error rate and good power in all cases. mˆBS-boot
lacks power as compared to mˆ-boot, and n-boot fails to control the type I
error rate (see Table S3 in the Supplementary Materials).
We also compare our methods with the kernel based method proposed
by Shen and Cai (2016) (KMl) and the GESATmethod proposed by Lin et al.
(2013) for the global test of no treatment-by-covariate interactions. Both
KMl and GESAT are designed to test for the integrated effect of all covari-
ates, with KMl based on randomized trials and GESAT based on correct
specification of both main effect of covariates and interaction effects. As
a result, we expect that KMl and GESAT are more powerful in the case
of weak dense signals while our method works better in the case of strong
sparse signals. This is indeed the case (see Table S4 in the Supplementary
Materials). All methods perform better when covariates are correlated.
In addition, KMl fails to control type I error rate in observational studies
and GESAT fails when the main effect is misspecified (see Table S5 in the
Supplementary Materials).
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5.2 Nefazodone-CBASP trial example
The Nefazodone-CBASP trial was conducted to compare the efficacy of
three treatments for chronic depression (Keller et al. 2000). In this trial,
681 patients were randomly assigned to 12 weeks of outpatient treatment
with nefazodone, the cognitive behavioral-analysis system of psychotherapy
(CBASP), or the combination of the two treatments. Various assessments
were taken throughout the study, among which the score on the 24-item
Hamilton Rating Scale for Depression (HRSD) was the primary outcome.
Low HRSD scores are desirable. Primary analysis showed that, on average,
the combination treatment was significantly better than any single treat-
ment (p-value < 0.001 for both comparisons), and there was no overall
difference between two single treatments.
In the current analysis, we conduct two comparisons: combination vs
nefazodone alone and combination vs. CBASP alone, to see if there is any
covariate-by-treatment interactions. The outcome Y is reduction in 24-
item HRSD score from baseline, and there are 50 baseline covariates. We
consider n = 656 patients for which the final 24-item HRSD were observed.
In both comparisons, we estimate φ˜(X) = E(Y |X) by ridge regressions,
and carry out the sequential tests in 5-steps. The selected covariates and
p-values from different methods are presented in Table 1.
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For comparison of combination treatment vs. CBASP alone (n=438),
the regular n-boot suggests three important covariates: Subthreshold panic
disorder (p = 0.016), Psychotherapy for past depression (p = 0.034), and
Alcohol abuse (p = 0.050). However, this is not supported by any other
methods. For comparison of combination treatment vs Nefazodone alone
(n = 440), again regular n-boot identifies three covariates: Psychotherapy
for past depression (p < 0.001), Alcohol dependence (p = 0.020), and Ob-
sessive compulsive disorder (p = 0.030). With LRT, all p-values are greater
than 0.1. In between, the NULL, mˆ-boot and BONF methods show that
only “Psychotherapy for past depression” has a p-value less than 0.1, which
indicates that this may be worth further investigation.
5.3 COPES and CODIACS example
The COPES and CODIACS studies were conducted to compare the stepped
care approach to standard care for patients with post-ACS (acute coro-
nary syndrome) depression (Davidson et al. 2010, 2013). Each trial enrolled
about 150 patients. In both trials, patients were randomly assigned to 6
months of stepped care or usual care. Stepped Care participants were as-
signed to psychotherapy and/or antidepressant based on their preferences
and a team of clinicians’ recommendations. Usual care participants re-
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Table 1: p-values of sequentially selected covariates in the Nefazodone-
CBASP trial example. (PD: Panic Disorder; PsyPD: Psychotherapy for
Past Depression; GAD: Generalized Anxiety Disorder; MDD: Major De-
pression Disorder; OCD: Obsessive Compulsive Disorder; AD-NOS: Anxi-
ety Disorder not otherwise specified.)
Steps Covariates selected NULL mˆ-boot n-boot LRT BONF
Combination vs CBASP
1 Subthreshold PD 0.628 0.578 0.016 0.792 1.000
2 PsyPD 0.622 0.754 0.034 0.903 1.000
3 Alcohol abuse 0.764 0.302 0.050 0.966 1.000
4 Threshold GAD 0.983 0.946 0.832 0.990 1.000
5 moderate MDD 0.993 0.564 0.622 0.994 1.000
Combination vs Nefazodone
1 Past Psychotherapy 0.096 0.088 0.000 0.147 0.086
2 Alcohol dependence 0.369 0.122 0.020 0.386 0.458
3 OCD 0.562 0.758 0.030 0.604 0.862
4 AD-NOS 0.907 0.296 0.122 0.774 1.000
5 Atypical MDD 0.925 0.564 0.140 0.852 1.000
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ceived psychotherapy and/or antidepressant from their current physicians.
Depressive symptom changes, assessed with the Beck Depression Inventory
(BDI) score, was the primary outcome for CODIACS and a secondary out-
come for COPES.
As an illustrative example, for the combined data from the above two
studies, we consider treatment A as whether a patient had received psy-
chotherapy more than half of the time during the 6-month study period.
Note that while the original two studies were randomized trials, the “treat-
ment received” variable A as defined above is observational in nature. There
are 26 baseline covariates, including patient demographics, symptoms, and
severity of symptoms in different domains (cardiac, depression, etc). The
outcome is reduction in BDI at 6 months from baseline. The sample size
n = 265 for which the final BDI and treatment information are available.
For the propensity score model, after initial analysis we find that the
treatment A as defined above strongly depends on the treatment arm and
patient preference. So we estimate the propensity score by logistic regres-
sion with treatment preference and whether the patient was assigned to
stepped care or usual care. The main effect h0(X) = E(Y |X, A = 0) is
estimated using ridge regression with 26 baseline covariates using patients
in the A = 0 group. We conduct 5 steps sequential tests, and the results
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from mˆ-boot and n-boot are presented in Table 2. The n-boot identifies
two important treatment-by-covariate interactions: NEMC Role limitation
emotional T-score (p = 0.004) and GRACE score (p = 0.024), while our
proposed mˆad-boot method suggests that only NEMC Role limitation emo-
tional T-score may be worth further investigation.
Table 2: p-values of sequentially selected covariates in the COPES and
CODIACS example.
Steps Covariates selected mˆ-boot-DR n-boot
1 NEMC Role limitation emotional T-score 0.028 0.004
2 GRACE score 0.330 0.024
3 NEMC General health T-score 0.504 0.112
4 BDI≥ 29 0.672 0.186
5 Prefer psychotherapy only 0.690 0.232
6. Discussion
This paper develops a novel inference procedure to sequentially identify
treatment-by-covariate interactions based on data from randomized trials
as well as observational studies. The proposed method guarantees rigorous
control of type I error rate at each step, and has greater power than com-
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peting testing procedures. Although derivation of the asymptotic results
assumes fixed dimension p, numerical studies evidenced that the proposed
test continues to work when p is large. Theoretical investigation of the
diverging p case is a challenging and interesting topic for future research.
Another challenge is to provide theoretical support to effectively control
the false positive rate over the whole sequence of forward stepwise path.
As discussed in Tibshirani et al. (2016), sequential testing is typically only
validated at each step. G’Sell et al. (2016) proposed stopping rules for exact
control of ordered false discovery rate control under the assumption that
the null p-values are independent. It would be worthwhile to study how to
extend their methods to our setting so that the stepwise guarantees can be
converted into stopping rules with desired inferential properties.
In this paper we consider the case of binary treatments. When there
are more than two treatments (e.g. L arms), the interaction effect between
treatment and a covariate includes L − 1 terms, and a test statistic can
be built based on the sum of square of the L − 1 standardized parameter
estimates. This would be an interesting extension for future research.
We have restricted attention to a single-stage treatment-by-covariate
interaction problem. However, time-varying treatments are common, and
are needed, e.g., for individuals with a chronic disease who experience a
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waxing and waning course of illness. The goal then is to identify infor-
mative covariates of treatment effect at each stage. Q-learning and A-
learning are extensions of regression to multi-stage setting (Murphy 2003,
2005; Moodie, Richardson and Stephens 2007; Schulte et al. 2014). It is
well known that the regression coefficients for variables at stages prior to the
last are non-regular (Robins 2004; Moodie, Richardson and Stephens 2010;
Chakraborty, Murphy and Strecher 2010; Chakraborty, Laber and Zhao 2013;
Laber et al. 2014; Song et al. 2015). In that case, the selection procedure
adds another layer of non-regularity to this already non-regular problem.
It would be interesting albeit challenging to extend our approach to the
multi-stage setting. We view this as an important future work.
Supplementary Materials
The online supplementary materials contain proofs of the theorems,
extension of Theorem 1 to non-unique k0, discussion of the doubly robust
method in randomized trials, and details of simulation studies.
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A. Assumptions of Theorems 4
Theorem 4 requires the following assumptions.
(A1) EX4k <∞ for k = 1, . . . , p.
(A2) There exist functions h˜(X) and q˜(X) such that n1/2[hˆn(x)− h˜(x)] =
∆h(x)Sˆh + oP (1) and n
1/2[qˆn(x) − q˜(x)] = ∆q(x)Sˆq + oP (1), where
∆h(x) and ∆q(x) are vector-valued deterministic functions of x, and
Sˆh and Sˆq are data dependent random vectors satisfying
i). ∆h(X) and ∆q(X) are square integrable random vectors; and
ii)
({
Gn
[
W˜Lk
(
Y − h˜(X)− ψkALk −E
[
W˜
(
Y − h˜(X)
)
X˜
T
J
]
×
[
E
(
AW˜X˜JX˜
T
J
)]−1
AX˜J
)]}
k∈JC
, Sˆh, Sˆq
)T
d→ ({Zok : k ∈ JC}, Sh, Sq)T ∼ N(0,Σo)
for some variance-covariance matrix Σo assumed to exist.
(A3) The error term ǫ in model (2.1) has mean zero, finite variance, and is
uncorrelated with (W˜ , W˜X), where W˜ = A− q˜(X).
32
(A4) ko0 is unique when β0,JC 6= 0.
(A5) q˜(X) = q0(X) or h˜(X) = h0(X) a.s.
(A6) Let qˆ∗m(X) and hˆ
∗
m(X) be estimates of q0(X) and h0(X) based on
the bootstrap sample of size m. Assume m1/2[hˆ∗m(x) − hˆn(x)] =
∆h(x)Sˆ
∗
h+ oPM (1) and m
1/2[qˆ∗m(x)− qˆn(x)] = ∆q(x)Sˆ∗q + oPM (1) con-
ditionally on the data (in probability), where ∆h(x) and ∆q(x) are
defined in Assumption (A2), and Sˆ∗h and Sˆ
∗
q are bootstrap sample
dependent random vectors satisfying({
G
∗
m
[
W˜Lk
(
Y − h˜(X)− ψkALk − E
[
W˜
(
Y − h˜(X)
)
X˜
T
J
]
×
[
E
(
AW˜X˜JX˜
T
J
)]−1
AX˜J
)]}
k∈JC
, Sˆ∗h, Sˆ
∗
q
)T
d→ ({Zok : k ∈ JC}, Sh, Sq)T ∼ N(0,Σo) conditionally, in probability.
Remark 1. {Z˜k : k ∈ JC} in Theorem 4 is defined as, for k ∈ JC ,
Z˜k = Z
o
k − E
[
W˜Lk∆h(X)
]
Sh −E
{
Lk
(
Y − h˜(X)− ψkALk
− E
[
W˜
(
Y − h˜(X)
)
X˜
T
J
][
E
(
AW˜X˜JX˜
T
J
)]−1
AX˜J
)
∆q(X)
}
Sq (A.1)
Remark 2. Assumptions (A2) and (A6) require that the original sam-
ple and bootstrap sample estimates of h0(x) and q0(x) are well behaved.
One can verify that, under appropriate conditions, the assumptions hold
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when h0(x) and q0(x) are estimated using linear/logistic regression, ridge
regression, or variable selection methods with oracle properties (e.g. SCAD
(Fan and Li 2001), adaptive Lasso (Zou and Hastie 2005)).
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